Patricia Fernandez

Publicaciones destacadas

• Understanding the microenvironment contribution to ductal carcinoma in situ transition to invasiveness in breast cancer

  Autores:

  Moragas, Nuria; Recalde-Percaz, Leire; Noguera-Castells, Aleix; Fernandez-Nogueira, Patricia; Mancino, Mario;

  Gascon, Pedro; Fuster, Gemma.

  Referencia: CANCER RESEARCH.

• Differential expression of neurogenes among breast cancer subtypes identifies high risk patients

  Autores:

  Fernandez-Nogueira, Patricia; Bragado, Paloma; Almendro, Vanessa; Ametller, Elisabet; Rios, Jose;

  Choudhury, Sibgat; Mancino, Mario; Gascon, Pedro;.

  Referencia: ONCOTARGET.

• Substance P Autocrine Signaling Contributes to Persistent HER2 Activation That Drives Malignant Progression and Drug Resistance in Breast Cancer

  Autores:

  Fernandez Ruiz, Pedro Luis; Garcia-Recio, Susana; Fuster, Gemma; Fernandez-Nogueira, Patricia; Pastor-Arroyo, Eva M;

  (...)

  Engel, Pablo; Costamagna, Domiziana; Fernandez, Pedro L; Gascon, Pedro; Almendro, Vanessa.

  Ver listado completo de autores

  Referencia: CANCER RESEARCH.

• A methodology for the isolation, culture, and immortalization of human breast epithelial and myoepithelial cells.

  Autores:

  Fuster, Gemma; Zubeldia-Plazaola, Arantzazu; Mancino, Mario; Fernandez-Nogueira, Patricia; Ametller, Elisabet;

  Gascon, Pedro; Almendro, Vanessa;.

  Referencia: MOLECULAR CANCER THERAPEUTICS.

• The New Antitumor Drug ABTL0812 Inhibits the Akt/mTORC1 Axis by Upregulating Tribbles-3 Pseudokinase

  Autores:

  Erazo, Tatiana; Lorente, Mar; Lopez-Plana, Anna; Munoz-Guardiola, Pau; Fernandez-Nogueira, Patricia;

  (...)

  Gomez-Ferreria, Mariana; Alfon, Jose; Velasco, Guillermo; Domenech, Carles; Lizcano, Jose M.;.

  Ver listado completo de autores

  Referencia: CLINICAL CANCER RESEARCH.

• Subtype specific expression of HRH1 contributes to increased chemoresistance of breast cancer cells

  Autores:

  Mancino, Mario; Fernandez-Nogueira, Patricia; Enreig, Estel; Ametller, Elisabet; Gascon, Pedro;

  Almendro, Vanessa;.

  Referencia: MOLECULAR CANCER RESEARCH.

• Targeting of substance P induces cancer cell death and decreases the steady state of EGFR and Her2

  Autores:

  Mayordomo, Cristina; Garcia-Recio, Susana; Ametller, Elisabet; Fernandez-Nogueira, Patricia; Maria Pastor-Arroyo, Eva;

  Vinyals, Laia; Casas, Ignasi; Gascon, Pedro; Almendro, Vanessa.

  Referencia: JOURNAL OF CELLULAR PHYSIOLOGY.

• Tumor promoting effects of CD95 signaling in chemoresistant cells

  Autores:

  Ametller, Elisabet; Garcia-Recio, Susana; Costamagna, Domizziana; Mayordomo, Cristina; Fernandez-Nogueira, Patricia;

  Carbo, Neus; Pastor-Arroyo, Eva Maria; Gascon, Pedro; Almendro, Vanessa.

  Referencia: MOLECULAR CANCER.

• Histamine receptor 1 inhibition enhances antitumor therapeutic responses through extracellular signal-regulated kinase (ERK) activation in breast cancer

  Autores:

  Fernández-Nogueira P.; Noguera-Castells A.; Fuster G.; Recalde-Percaz L.; Moragas N.;

  (...)

  Carbó N.; Almendro V.; Gascón P.; Bragado P.; Mancino M..

  Ver listado completo de autores

  Referencia: CANCER LETTERS.